ANAPTYSBIO INC
Net SellingANAB·US·🇺🇸 US
35%buys·65%sales
747 transactions$218.8MTotal buys·59 buys
$89.0MTotal sells·112 sells
3838 insiders
Last: Mar 30, 2026
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Mar 30, 26 | Schmid John P. | Sell | $30K | |
| Mar 30, 26 | Schmid John P. | Sell | $427K | |
| Mar 30, 26 | Schmid John P. | Sell | $702K | |
| Dec 23, 25 | Schmid John P. | Other | $564K | |
| Dec 23, 25 | Ware J. Anthony | Sell | $193K | |
| Dec 22, 25 | LOUMEAU ERIC J | Exercise | - | |
| Dec 22, 25 | MULROY DENNIS | Exercise | - | |
| Dec 22, 25 | Lizzul Paul F. | Exercise | - | |
| Dec 22, 25 | LOUMEAU ERIC J | Exercise | $140K | |
| Dec 22, 25 | LOUMEAU ERIC J | Sell | $510K |
LOUMEAU ERIC J (CFO) recently executed a sell of $510K in ANAPTYSBIO INC shares on December 22, 2025. Overall insider sentiment is bearish (65% sales).
ANAPTYSBIO INC (ANAB) has recorded 747 insider operations, including 59 open-market purchases ($218.8M), 112 sales ($89.0M) and 576 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bearish (65% sales).
ANAPTYSBIO INC shows moderate insider activity with 6 active months out of the last 12, typical of a company whose trading windows are concentrated around financial disclosures.
Among the most active insiders are Faga Daniel (CEO), Suria Hamza (CEO) & MULROY DENNIS (CFO), with respectively 72, 67, 105 transactions.
Across all 747 recorded transactions, the breakdown by type is: exercise (377, 50%), grant (156, 21%), sales (112, 15%), buys (59, 8%), other (34, 5%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
ANAPTYSBIO INC has recorded 747 insider operations in total, including 59 open-market purchases ($218.8M), 112 sales ($89.0M) and 576 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on March 30, 2026.
Insiders at ANAPTYSBIO INC are currently net sellers, with 35% purchases and 65% sales across all reported transactions. Total buy volume is $218.8M versus $89.0M in sales, indicating a bearish insider sentiment.
InsiderLens tracks 38 insiders at ANAPTYSBIO INC (ANAB). Faga Daniel (CEO, 72 tx), Suria Hamza (CEO, 67 tx), MULROY DENNIS (CFO, 105 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for ANAB is bearish, based on a 35% buy ratio across 171 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for ANAPTYSBIO INC comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.